art-header-clip
ExploreTrial

                                                  btnGotoERCF

EXPLORE COMPLETED!!!!

304 patients enrolled!

Conclusion

After evaluation of the abovementioned data, we can conclude that the presence of a CTO drives mortality in STEMI patients with MVD and is associated with a reduced LVEF and a further reduction of LVEF.

This data has lead us to the explore trial, which will investigate the effect of CTO revascularization within the first week, on left ventricular function.